FDA Adds Fatal Risk Warning to J&J and Legend Biotech’s Carvykti Cancer Therapy 
Canada Loses Measles-Free Status After Nearly 30 Years Amid Declining Vaccination Rates 
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage 
Eli Lilly’s Weight-Loss Pill Nears Fast-Track FDA Approval as Profits Surge on Global Demand 
EU Signals Major Shift on 2035 Combustion Engine Ban Amid Auto Industry Pressure 
Australia Enforces World-First Social Media Age Limit as Global Regulation Looms 
Obamacare Premiums Set to Double in 2026 as Subsidy Expiration Looms Amid U.S. Shutdown 
Trump Set to Begin Final Interviews for Next Federal Reserve Chair 
Novo Nordisk Appoints Greg Miley as Global Head of Corporate Affairs Amid U.S. Pricing Pressure 
Pfizer Sues Novo Nordisk Over Alleged Tactics to Block Obesity Drug Competition 
Sydney Bondi Beach Terror Attack Kills 16, Sparks Gun Law and Security Debate 
Bayer’s Stroke Drug Achieves Breakthrough Trial Results, Boosting Market Confidence 
FAA Unveils Flight Plan 2026 to Strengthen Aviation Safety and Workforce Development 
DOJ Sues Loudoun County School Board Over Transgender Locker Room Policy 
Australia’s Under-16 Social Media Ban Sparks Global Debate and Early Challenges 
Innovent’s Xinermei Intensifies Weight-Loss Drug Battle in China 
The U.S. Centers for Disease Control and Prevention (CDC) has revised its guidance on COVID-19 vaccines for children, stating that vaccination for healthy individuals aged 6 months to 17 years should follow a “shared clinical decision-making” process. This means that shots are still available, but only if parents and doctors agree it's necessary based on individual circumstances.
The move marks a shift from earlier CDC guidance, which broadly recommended updated COVID-19 vaccines for everyone six months and older. The updated schedule, published Thursday, outlines that if parents want their child vaccinated, they may proceed based on a healthcare provider’s judgment and the family’s preference.
Health Secretary Robert F. Kennedy Jr., a known vaccine skeptic, claimed earlier in the week that COVID vaccines for healthy children and pregnant women had been removed from the CDC’s immunization schedule. However, a Department of Health and Human Services spokesperson said there is no contradiction, as the CDC’s updated guidance no longer promotes universal vaccination for healthy children but still allows it case-by-case.
Medical experts criticized Kennedy’s unilateral announcement, saying it bypassed the CDC’s usual advisory process. The Infectious Diseases Society of America warned the change may limit access and insurance coverage, especially for vulnerable children. They emphasized that COVID-19 can cause serious illness in children, including long COVID symptoms that may impact development.
According to CDC data, nearly 1,900 children under 18 have died from COVID-19 in the U.S. as of 2023. Vaccine makers Pfizer, Moderna, and Novavax have not commented on the development.
The FDA also recently announced it would require new clinical trials for annual COVID boosters in healthy individuals under 65, reinforcing a more limited use strategy moving forward.
